|
- 2018
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in CanadaDOI: 10.1007/s41669-017-0030-7 Abstract: The online version of this article (doi:10.1007/s41669-017-0030-7) contains supplementary material, which is available to authorized users
|